« Back
Home /
Yohimbine (Hydrochloride)

Yohimbine (Hydrochloride)

Item no.	HY-N0127-10mM
Manufacturer	MedChem Express
CASRN	65-19-0
Amount	10 mM/1 mL
Quantity options	10 mM/1 mL 1 g 500 mg
Category	Food Safety Hormones Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Clone	N/A
Specific against	other
Purity	99.91
Formula	C21H27ClN2O3
Citations	[1]Docherty JR, et al. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4. [2]Docherty JR. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4. [3]Damase-Michel C, et al. The effect of yohimbine on sympathetic responsiveness in essential hypertension. Eur J Clin Pharmacol. 1993;44(2):199-201. [4]Musso NR, et al. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens. 1995 Jun;8(6):565-71. [5]Sáiz J, et al. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacol Rep. 2008 May-Jun;60(3):391-8. Eur J Pharmacol. 2023 Nov 6:176174. Exp Neurobiol. 2020 Oct 31;29(5):356-375. Mol Biol Rep. 2020 May;47(5):3629-3639. Mol Med Rep. 2020 Jul;22(1):175-184. Neurosci Bull. 2022 Apr;38(4):386-402. Biomed Pharmacother. 2022 Apr 26;150:113006. Drug Des Devel Ther. 2024 Apr 9:18:1103-1114. Eur J Neurosci. 2021 Nov 4. J Neuroinflammation. 2022 May 27;19(1):123. J Neurophysiol. 2023 Apr 12. Research Square Preprint. 2023 Dec 16.
Smiles	[H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5(CC[C@H](O)[C@H](C(OC)=O)[C@]5(C2)[H])[H].[H]Cl
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	65-19-0
Shipping condition	Room temperature
Available
Manufacturer - Type	Natural Products
Manufacturer - Targets	Adrenergic Receptor
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	390.90
Product Description	Yohimbine hydrochloride is an alpha-2 renal adenomatase receptor inhibitor, blocking pre- and post-contact alpha-2 renal adenomatase receptors, causing the release of renal adenoma and multiple sclerosis.
Manufacturer - Research Area	Endocrinology
Solubility	DMSO : 33.33 mg/mL (ultrasonic)\|H2O : 3.33 mg/mL (ultrasonic)
Manufacturer - Pathway	GPCR/G Protein; Neuronal Signaling
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-N0127-10mM-safety-datasheet.pdf